Pharmacokinetic studies of flumecinol in man and dog

I. Klebovich, L. Vereczkey, S. Kerpel-Fronius, G. Ringwald, I. Bodrogligeti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pharmacokinetics of flumecinol (Zixoryn®) a new hepatic enzyme inducer has been studied in four beagle dogs and six healthy volunteers. The beagle dogs and the volunteers received the drug orally in a dose of 40 mg/kg of body weight and of 100 mg single dose respectively. Flumecinol was extracted from plasma with diethyl ether and analysed by gas-liquid chromatography using a flame ionisation detector (FID). The pharmacokinetic parameters of flumecinol were determined by computer evaluation of the plasma concentration-time curves. The peak plasma concentrations were found to be 3.3 and 2.1 hours in dogs and humans, respectively. Flumecinol is eliminated from the plasma of dogs and humans with half-lives of 38.95 and 17.16 hours, corresponding to a clearance of 53.2 litres/hour and 94.0 litres/hour, respectively.

Original languageEnglish
Pages (from-to)99-104
Number of pages6
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Volume7
Issue number2
DOIs
Publication statusPublished - Apr 1982

Fingerprint

Pharmacokinetics
Dogs
Flame Ionization
Gas Chromatography
Ether
Volunteers
Healthy Volunteers
Body Weight
flumecinol
Liver
Enzymes
Pharmaceutical Preparations

Keywords

  • dog
  • enzyme inducer
  • Flumecinol
  • man
  • pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacokinetic studies of flumecinol in man and dog. / Klebovich, I.; Vereczkey, L.; Kerpel-Fronius, S.; Ringwald, G.; Bodrogligeti, I.

In: European Journal of Drug Metabolism and Pharmacokinetics, Vol. 7, No. 2, 04.1982, p. 99-104.

Research output: Contribution to journalArticle

Klebovich, I. ; Vereczkey, L. ; Kerpel-Fronius, S. ; Ringwald, G. ; Bodrogligeti, I. / Pharmacokinetic studies of flumecinol in man and dog. In: European Journal of Drug Metabolism and Pharmacokinetics. 1982 ; Vol. 7, No. 2. pp. 99-104.
@article{9ba5c267f2c2408eb52b4e7a47c17522,
title = "Pharmacokinetic studies of flumecinol in man and dog",
abstract = "The pharmacokinetics of flumecinol (Zixoryn{\circledR}) a new hepatic enzyme inducer has been studied in four beagle dogs and six healthy volunteers. The beagle dogs and the volunteers received the drug orally in a dose of 40 mg/kg of body weight and of 100 mg single dose respectively. Flumecinol was extracted from plasma with diethyl ether and analysed by gas-liquid chromatography using a flame ionisation detector (FID). The pharmacokinetic parameters of flumecinol were determined by computer evaluation of the plasma concentration-time curves. The peak plasma concentrations were found to be 3.3 and 2.1 hours in dogs and humans, respectively. Flumecinol is eliminated from the plasma of dogs and humans with half-lives of 38.95 and 17.16 hours, corresponding to a clearance of 53.2 litres/hour and 94.0 litres/hour, respectively.",
keywords = "dog, enzyme inducer, Flumecinol, man, pharmacokinetics",
author = "I. Klebovich and L. Vereczkey and S. Kerpel-Fronius and G. Ringwald and I. Bodrogligeti",
year = "1982",
month = "4",
doi = "10.1007/BF03188725",
language = "English",
volume = "7",
pages = "99--104",
journal = "European Journal of Drug Metabolism and Pharmacokinetics",
issn = "0378-7966",
publisher = "Springer Paris",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetic studies of flumecinol in man and dog

AU - Klebovich, I.

AU - Vereczkey, L.

AU - Kerpel-Fronius, S.

AU - Ringwald, G.

AU - Bodrogligeti, I.

PY - 1982/4

Y1 - 1982/4

N2 - The pharmacokinetics of flumecinol (Zixoryn®) a new hepatic enzyme inducer has been studied in four beagle dogs and six healthy volunteers. The beagle dogs and the volunteers received the drug orally in a dose of 40 mg/kg of body weight and of 100 mg single dose respectively. Flumecinol was extracted from plasma with diethyl ether and analysed by gas-liquid chromatography using a flame ionisation detector (FID). The pharmacokinetic parameters of flumecinol were determined by computer evaluation of the plasma concentration-time curves. The peak plasma concentrations were found to be 3.3 and 2.1 hours in dogs and humans, respectively. Flumecinol is eliminated from the plasma of dogs and humans with half-lives of 38.95 and 17.16 hours, corresponding to a clearance of 53.2 litres/hour and 94.0 litres/hour, respectively.

AB - The pharmacokinetics of flumecinol (Zixoryn®) a new hepatic enzyme inducer has been studied in four beagle dogs and six healthy volunteers. The beagle dogs and the volunteers received the drug orally in a dose of 40 mg/kg of body weight and of 100 mg single dose respectively. Flumecinol was extracted from plasma with diethyl ether and analysed by gas-liquid chromatography using a flame ionisation detector (FID). The pharmacokinetic parameters of flumecinol were determined by computer evaluation of the plasma concentration-time curves. The peak plasma concentrations were found to be 3.3 and 2.1 hours in dogs and humans, respectively. Flumecinol is eliminated from the plasma of dogs and humans with half-lives of 38.95 and 17.16 hours, corresponding to a clearance of 53.2 litres/hour and 94.0 litres/hour, respectively.

KW - dog

KW - enzyme inducer

KW - Flumecinol

KW - man

KW - pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=0019945754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019945754&partnerID=8YFLogxK

U2 - 10.1007/BF03188725

DO - 10.1007/BF03188725

M3 - Article

C2 - 7117300

AN - SCOPUS:0019945754

VL - 7

SP - 99

EP - 104

JO - European Journal of Drug Metabolism and Pharmacokinetics

JF - European Journal of Drug Metabolism and Pharmacokinetics

SN - 0378-7966

IS - 2

ER -